Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

Early Phase 1
2(66.7%)
N/A
1(33.3%)
3Total
Early Phase 1(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06645314Early Phase 1Not Yet Recruiting

Study on the Safety and Efficacy of BST06 Injection in the Treatment of Advanced Hepatocellular Carcinoma

Role: collaborator

NCT06643910Not ApplicableNot Yet Recruiting

A Study on the Safety and Efficacy of BST08 in Treating Advanced Non-Small Cell Lung Cancer

Role: collaborator

NCT06645301Early Phase 1Not Yet Recruiting

BGT007 Treatment for Recurrent/refractory Gastrointestinal Malignancies

Role: collaborator

All 3 trials loaded